Role of CCR5 in the pathogenesis of IL-13-induced inflammation and remodeling
Bing Ma1, Wei Liu, Robert J Homer
1Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract:
IL-13 is a major effector at sites of Th2 inflammation and tissue remodeling. In these locations, it frequently coexists with the CCR5 chemokine receptor and its ligands MIP-1alpha/CCL3 and MIP-1beta/CCL4. We hypothesized that CCR5 induction and activation play important roles in the pathogenesis of IL-13-induced tissue responses. To test this hypothesis, we evaluated the effects of IL-13 on the expression of CCR5 in the murine lung. We also compared the effects of lung-targeted transgenic IL-13 in mice treated with anti-CCR5 or an Ab control and mice with wild-type or null CCR5 loci. These studies demonstrate that IL-13 is a potent stimulator of epithelial cell CCR5 expression. They also demonstrate that CCR5 neutralization or a deficiency of CCR5 significantly decreases IL-13-induced inflammation, alveolar remodeling, structural and inflammatory cell apoptosis, and respiratory failure and death. Lastly, these studies provide mechanistic insights by demonstrating that CCR5 is required for optimal IL-13 stimulation of select chemokines (MIP-1alpha/CCL3, MIP-1beta/CCL4, MCP-1/CCL-2), matrix metalloproteinase-9 and cell death regulators (Fas, TNF, TNFR1, TNFR2, Bid), optimal IL-13 inhibition of alpha1-antitrypsin, and IL-13-induction of and activation of caspases-3, -8, and-9. Collectively, these studies demonstrate that CCR5 plays a critical role in the pathogenesis of IL-13-induced inflammation and tissue remodeling.
Insights
Interleukin-13 (IL-13) drives tissue damage by inducing the CCR5 receptor. Blocking CCR5 reduces IL-13-mediated inflammation, remodeling, and respiratory failure, highlighting CCR5
Area of Science:
- Immunology and Inflammation Research
- Respiratory Medicine
- Molecular Biology
Background:
- Interleukin-13 (IL-13) is a key cytokine in Th2-mediated inflammation and tissue remodeling.
- The chemokine receptor CCR5 and its ligands are often present at sites of IL-13 activity.
- The role of CCR5 in IL-13-induced pathogenesis remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of CCR5 in the development of IL-13-induced lung inflammation and tissue remodeling.
- To determine if IL-13 influences CCR5 expression in the murine lung.
- To assess the impact of CCR5 blockade or deficiency on IL-13-driven pathological outcomes.
Main Methods:
- Evaluating CCR5 expression in response to IL-13 in murine lungs.
- Comparing IL-13-induced responses in mice treated with anti-CCR5 antibodies versus controls.
- Utilizing wild-type and CCR5-deficient mice to assess CCR5's role in IL-13 pathogenesis.
- Analyzing the expression of chemokines, matrix metalloproteinases, cell death regulators, and caspases.
Main Results:
- IL-13 significantly stimulates CCR5 expression in epithelial cells.
- Neutralization or absence of CCR5 markedly reduces IL-13-induced inflammation, alveolar remodeling, apoptosis, and mortality.
- CCR5 is essential for optimal IL-13-mediated induction of specific chemokines, MMP-9, and cell death pathways.
- CCR5 is required for IL-13's effects on alpha1-antitrypsin inhibition and caspase activation.
Conclusions:
- CCR5 plays a critical role in the pathogenesis of IL-13-induced lung inflammation and tissue remodeling.
- Targeting CCR5 may offer a therapeutic strategy for IL-13-driven respiratory diseases.
- IL-13 and CCR5 signaling pathways are intricately linked in the context of Th2 inflammation.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammation: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

